Skip to content

Pulsar-18 T3 5/100/90Recalls & reported problems

Biotronik AG · Class 3 · Implant

All models of Pulsar-18 T3 (52)

Data updated Oct 18, 2026 from official FDA records · Editorial policy

Adverse event reports
1
Deaths reported
0
Injuries reported
0
Recalls naming it
0

Summary

The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 07640130446502), received between Mar 17, 2020 and Mar 17, 2020 — classified as 1 malfunction.

The most frequently reported specific device problem is “Fracture” (1 report).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.

Most reported problems

Device problems

  • Fracture1

Patient problems

  • No Consequences Or Impact To Patient1

Recent adverse event reports

The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.

  • MalfunctionMar 17, 2020Fracture; Fracture

    A PULSAR-18 T3 STENT SYSTEM WAS CHOSEN FOR TREATMENT OF A CALCIFIED LESION IN A TORTUOUS SFA. AFTER SUCCESSFUL DEPLOYMENT OF THE STENT THE DEVICE WAS REMOVED FROM THE PATIENTS BODY. THEN IT WAS DETECTED THAT THE INNER SHAFT REMAINED ON THE GUIDE WIRE AND WAS SEPARATED FROM THE SYSTEM.

    Patient problems: No Consequences Or Impact To Patient

    MAUDE report 9838857 ↗

Other STENT, SUPERFICIAL FEMORAL ARTERY devices

All STENT, SUPERFICIAL FEMORAL ARTERY devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page